Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

From Service Provider to Strategic Partner
As drug development grows more complex and timelines compress, sponsors require CDMO relationships built on integration, flexibility, and shared accountability read more
An Interview With Kim Boericke
Veristat’s new CEO, Kim McLean Boericke, is one step closer to changing the tide in representing the small fraction of companies led by women and is now the only female with the highest job among the top-8 clinical research organizations (CROs). read more
Extreme Language Ultra-High Potency
The newest generation of small-molecule therapies bring containment needs well beyond those of conventional HPAPIs. What does this mean for the pharma lexicon – and the pharma landscape? read more
An Interview With Christoph van Eickels, Dr. Deepak Venkanna, and Holly Olmstead
Executive Q&A topic: Regulatory Requirements for Upstream Bioprocess Solutions read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

CPHI Americas to Relocate to Miami in 2027
Tuesday, June 02, 2026
Informa Markets, organizer of CPHI Americas, will move the event to Miami in 2027 to enhance international accessibility, increase executive ... read more
Veeva Quality Cloud to Support Kindeva’s Global Manufacturing Quality Platform
Monday, June 01, 2026
Veeva Systems said Kindeva is adopting Veeva Quality Cloud to modernize and standardize quality management across its global manufacturing network. read more
Gaelic Laboratories Earns BSI Kitemark Certification for Minimized AMR Risk
Monday, June 01, 2026
Gaelic Laboratories, a GMP-approved manufacturer of beta-lactam antibiotics, has obtained BSI Kitemark Certification for Minimized Risk of ... read more
LIFT, NorthStar Partner on Lu 177 LT17 Radioligand for Cancer-Associated Bone Disease
Monday, June 01, 2026
The Low Institute for Therapeutics (LIFT) and NorthStar have entered a strategic collaboration to advance Lu 177 LT17, a novel radioligand therapy for... read more
PharmaLogic, Ratio Therapeutics Expand Manufacturing Pact for [Ac-225]RTX-2358
Monday, June 01, 2026
PharmaLogic Holdings has expanded its manufacturing collaboration with Ratio Therapeutics to support clinical development and future commercialization... read more